IndraLab

Statements

Imatinib inhibits NFKB1. 2 / 2
| 2
reach
"According to these findings it was suggested that the decreased miR-146a expression observed in untreated CML cells could contribute to mediate the BCR and ABL induced NFkB constitutive activation; on the other hand, the increased miR-146a expression observed following imatinib treatment, could contribute to mediate the imatinib induced NFkB inhibition [XREF_BIBR]."
22453030
reach
"Imatinib treatment inhibit IL-6, IL-8, NF-KB and AP-1 production and modulate intracellular calcium in CML patients."
21938724